CJC-1295 w/o DAC – 5mg

CJC-1295 (w/o DAC) – Research Compound

CJC-1295 (without DAC) is a growth hormone–releasing hormone (GHRH) analog selected for laboratory investigation into growth hormone–associated signaling pathways and hypothalamic–pituitary regulatory mechanisms. It is commonly evaluated in controlled research environments examining receptor-mediated endocrine communication and pulsatile growth hormone pathway dynamics.

Within structured scientific models, researchers explore its relevance to downstream metabolic signaling processes, protein and lipid–associated biochemical pathways, and broader neuroendocrine regulatory frameworks. Ongoing investigation remains preliminary, model-specific, and highly dependent on experimental design and study conditions.

Research Applications

• Investigation of growth hormone–associated signaling pathways

• Evaluation of hypothalamic–pituitary regulatory mechanisms

• Study of receptor-mediated endocrine communication

• Analysis of protein and lipid–associated metabolic signaling

• Inclusion in endocrine and metabolic research models

For research use only. Not for human consumption.
This product is not approved by the U.S. Food and Drug Administration and is supplied strictly for laboratory, educational, and research purposes.